| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study |
Cyril Quivoron, Valérie Camara-Clayette, Vincent Ribrag |
01/01/2023
|
American Journal of Hematology |
| Postoperative radiotherapy in non-small cell lung cancer stage IIIA – N2: Focus and perspectives |
Boris Duchemann |
01/01/2023
|
Bulletin du Cancer |
| Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study |
Jean Yves Scoazec |
01/01/2023
|
Critical Reviews in Oncology/Hematology |
| Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study) |
Muriel Abbaci, Frederic de Leeuw, Corinne Laplace-Builhé |
01/12/2022
|
European Journal of Surgical Oncology |
| Re: Kara N. Maxwell, Heather H. Cheng, Jacquelyn Powers, et al. Inherited TP53 Variants and Risk of Prostate Cancer. Eur Urol 2022;81:243–50: Off-core Li-Fraumeni Syndrome Spectrum Cancers: Increasing Interest for Prostate Cancer? |
Etienne Rouleau |
01/12/2022
|
European Urology |
| CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia |
Yann Lécluse |
01/12/2022
|
Nature Communications |
| Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform |
Ludovic Lacroix |
01/12/2022
|
Scientific Reports |
| Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers |
Lydie Cassard, Lisa Boselli, Jonathan Grivel, Ludovic Lacroix, Nathalie Chaput |
01/12/2022
|
Journal of Experimental and Clinical Cancer Research |
| Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor |
Tudor Manoliu, Valérie Rouffiac, Karine Ser Le Roux |
01/12/2022
|
Stem Cell Research and Therapy |
| Quality assessment in light microscopy for routine use through simple tools and robust metrics |
Tudor Manoliu |
07/11/2022
|
Journal of Cell Biology |
| Genomics to select treatment for patients with metastatic breast cancer |
Alicia Tran-Dien |
13/10/2022
|
Nature |
| Escherichia coli–Specific CXCL13-Producing T<inf>FH</inf> Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle- Invasive Bladder Cancer |
Virginie Marty, Nicolas Signolle, Jean Yves Scoazec |
01/10/2022
|
Cancer Discovery |
| Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung Trial |
Ludovic Lacroix |
15/09/2022
|
Clinical Cancer Research |
| Impact of acetaminophen on the efficacy of immunotherapy in cancer patients |
Nathalie Chaput |
01/09/2022
|
Annals of Oncology |
| Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration |
Marc Deloger |
09/08/2022
|
Immunity |
| NF-κB signaling controls H3K9me3 levels at intronic LINE-1 and hematopoietic stem cell genes in cis |
M’Boyba Khadija Diop |
01/08/2022
|
Journal of Experimental Medicine |
| Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
Valérie Camara-Clayette |
01/08/2022
|
Haematologica |
